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ABSTRACT 
Gene variability is described as the amount of dispersion in the expression values of a gene 
within a determined dataset. This value have been studied to determine genes that are affected 
by high environmental regulation, identify transcriptional regulators. But may the study of highly 
variable genes characterize different cell populations or conditions as mean expression values 
does? In this present work, we have observed that in Single cell expression datasets, variable 
expressed genes analysis (using Seurat::VST procedure) allow us to identify unique pathways, 
functions and cell locations that, characterizing different cell types, degrees of relationship and 
differentiate homogeneous from heterogeneous datasets.  
  
INTRODUCTION 
Variability in Gene Expression 
Variability is described as the amount of dispersion in a given distribution, in the case of a 
biological analysis of gene expression, it would be considered as differences in expression within 
the same condition or “expression noise”. 
During the last decade several works have tried to assess whether gene expression variability 
can provide insights on different cell populations beyond those acquired from standard analysis 
of gene expression means [1][2].  
Analysis of gene variability within groups that are seemingly homogenous have so far been 
valuable to predict the outcome of diseases[3], shaping innate immunity [4] or identifying 
transcriptional regulators in the development of early human embryos[5]. In addition, 
identification of variably expressed genes (VEGs) can suggest disruptions or dysregulations of 
biological processes[1] .  
In this scenario, single cell RNA sequencing (scRNA-Seq) has opened new avenues to study gene 
variability in clonal subpopulations of a determined sample. Different mechanisms contribute to 
the variability in homogenous cell populations, ranging from inherent variations in the 
biochemical process of gene expression itself, intrinsic and extrinsic noise and phenotypic 
plasticity of cells due to variations in the local micro-environment[1]. 
Compared to classic bulk RNA-seq, data obtained with scRNA-Seq techniques has some specifics 
due to the low mRNA content available from each individual cell analyzed and the variability 
derived from phenotypic plasticity and technical bias. Given that, scRNA-Seq data features lower 
read counts, a higher amount of outliers[6]  and an increased inner variability between cells 
sharing the same conditions, being this variability more prominent in highly expressed genes[7]. 
These features result in a multimodal distribution for the expression values obtained[8]. 
This bimodal distribution is constructed as a mixture of Poisson distributions, where gene 
expression is modelled as a stochastic Poisson process depending on the RNA synthesis 
(influenced by the promotor of the gene and the upstream regulators), and RNA degradation, 
being both described as a  Poisson process. Considering this RNA birth-death becomes a doubly 
stochastic (mixed) Poisson process[9]. The negative binomial distribution represents a good 
intersection between computational complexity and biological simplicity as NB distribution is 
defined through only two parameters 
Statistics for dispersion measurement 
Three main statistics might be used to address variability, i.e. SD, CV and MAD, and all of them 
share some conceptual similarities in their mathematical definition (Figure 1)[10].  
SD: Is dependent on the value of average expression, but simulations have shown a lower 
correlation with average expression than previously expected [11]  
CV: Is affected by zero-inflation or near zero levels.  
MAD: Is a robust measurement of dispersion that behaves well in presence of outlier data 
points.  
A consensus on which estimator should be adopted to address variability have not been 
achieved yet, and performance is still data-specific [12]. SD and CV are easier to interpret as they 
are in the same dimensions as mean. In any of the cases, variability estimators are highly 
correlated with the average expression, then trends observed for expression variability may 
simply be recapitulated by those observed for average expression. In an ideal scenario, the 
estimator of gene expression variability should be uncorrelated with average gene expression 
Considerations for variability measurements 
Standard error of methods to calculate over-dispersion tend to be larger than those designed to 
address differences by mean estimates[12], causing that statistical analyses based  on average 
expression as DEG analysis [13]show higher reproducibility.  
Given that, and putting aside the effect of technical variability, there are some general 
considerations that must be taken into account in order to perform variability studies [11]. 
Sufficient amount of samples: Technical variability has a higher impact on variability studies 
than in mean expression analysis, therefore a significantly higher amount of samples is required  
Reducing batch effect: As technical bias adds a confusion effect to the variability measurement 
that can mask the biological dispersion of gene expression, is important to reduce its impact as 
much as possible. This can be achieved reducing batch effect distributing samples evenly 
through different batches, and also performing technical replicates. 
Figure 1: Main statistics used for variability determination for a given 
x dataset[10].   
Immune System 
 
Figure 2: Scheme of the Cell components of whole blood and different lineages within PBMCS. Cells analyzed in the 
present manuscript are highlighted in colour and marked with the cluster of differentiation (CD) used for it selection.  
Peripheral blood mononuclear cells (PBMCs) are blood cells featuring a round nucleus, including 
monocytes, lymphocytes, dendrytic cells and natural killer cells (Figure 2).  Isolation of PBMCs  
performed by centrifugation of peripheral blood supplemented with anticoagulants in a density 
gradient using a hydrophilic colloid[14]. 
Surface markers expressed by immune cells are referred as the Cluster of differentiation 
nomenclature (CD), a protocol stablished in 1991 to standardize the designation and 
identification of cell phenotypes. Even though a particular CD is not specific of a single cell type 
or even a whole lineage, when combined they are a very powerful tool for immune cells 
characterization. Even though the complete list of determinants features more than 350 
molecules with specific functions such as receptors for ligands and further signaling, cell 
adhesion, etc. Few of them are more widely spread for immune cells identification and isolation 
using flow cytometry procedures[15].  
 Table 1: Cell components of PBMCs in percentage and frequencies[16].  
The adaptive immune response is subdivided into functional groups representing 
humoral and cellular immunity, based on participation of the two major cell types. 
Humoral immunity involves B lymphocytes (also called B cells) which synthesize and 
secrete antibodies. Cellular immunity involves effector T lymphocytes(also called T cells) 
which secrete immune regulatory factors following interaction with specialized 
processing cells (called antigen presenting cells; APCs) that show the lymphocytes 
foreign material in the context of self-molecules[16]. 
Lymphocytes continuously leave the blood vessels, migrating throughout the body 
where they perform surveillance activities 
Lymphocyte lineages 
Leukocyte is the term given to any white blood cells that play a functional role in the 
immune response. They can be classified into two main groups depending on the 
developmental path taken during development in the bone marrow. 
Myeloid cells represent the first line of defense as the most important part of the innate 
immunity. They  provide a rapid response (in a range of minutes to hours) against 
pathogens in a nonspecific way, recognizing structural motifs and patters in molecules 
and secreting soluble activators and proinflammatory mediators, those mechanism 
involves no memory upon a future exposure[15]. Cells from myeloid lineage includes 
dendritic cells (involved in quick generic response to pathogens); phagocytic leukocytes 
as motile neutrophils, and monocytes (the circulating precursor of macrophages); 
eosinophils basophils and mast cells (in charge of parasite defense and allergic chain 
reactions). 
 In the other hand, lymphoid cell types are involved in specific immunity. Specific 
immunity creates a specific response to pathogens, creating a memory that will allow 
the organism to develop a quicker response to a future exposure, mediated by 
antibodies and cytokines. Lymphoid cells have receptors to recognize and physically 
interact with antigens, B lymphocytes and the T lymphocytes. A functionally related set 
of cells considered also as lymphoid are the natural killer cells(NK cells). 
In this manuscript we will focus on those cells selected by the following CDs: CD14 
(Monocytes), CD19 (B lymphocytes), CD4 (T Helper lymphocytes, CD56 (NKs), CD8 
(Cytotoxic T cells) and CD 34 (Hematopoietic precursors) (Table 2 and Figure 2). 
Monocytes (CD14) 
 Monocytes are the largest of the leukocytes, they belong to the myeloid lineage, along with 
macrophages and dendritic cells. They are produced in the bone marrow before and the  lifespan 
of a circulating monocyte is fairly brief and most undergo apoptosis after about 24 h[17].  
Monocytes develop into macrophages after leaving the cell circulation in different tissues, 
performing surveillance functions against pathogens or eliminating dead cells. Macrophages are 
able to detect products of bacteria and other microorganisms using different receptors as Toll-
like receptors (TLRs).The can also function as APCs to T cells and release cytokines to trigger and 
modulate immune cells (as seen in Helper T cells)[18]. 
Lymphoid Cells  
Lymphoid cells are the principal cells in charge of the acquired immunity, responding to 
pathogens (microbes and pathogens) after myeloid cells mediation[16].  
Lymphoid cells are separated in three lineages, the B Cells, the T cells and the NK cells.  
T cells 
T cells are produced in the thymus (where the T comes from) and mediate between cellular and 
humoral immunity. T Cells recognize antigens through their T cell receptor (TCR)[19]. But they 
cannot bind antigen directly, it needs to have processed by an antigen presenting cell (APC) and 
presented through the major histocompatibility complexes (MHC), a molecule present in APCs 
cell surface. Despite of the similarity with the antibody, TCR is only present on its surface and is 
not secreted when T cells are activated, and the TCR-MHC binding is unstable, requiring co-
receptors[20]. This presentation process requires a constant migracion of T cells to secondary 
lymphoid organs to encounter APCs.   
T Helper Cells (CD4) 
Helper T cells interact with the different mediators of adaptative immune response shaping their 
activity: Stimulating antibody production of B cells, activating Macrophages through IFNg[21], 
Citotoxic T Cells and recruiting antigen presenting cells. They also secret cytokynes that can act 
on epithelial and smooth muscle cells.  
CD4+T cells recognise peptides presented on MHC class II molecules, from antigen presenting 
cells (APCs), depending on the strength of TCR signaling and the cytokine microenvironment 
(Figure 3), activated T cells differentiate into distinct Th lineages[22]. Most of the modulations 
that T helper cells perform in the immune system (Figure 3) relies on the production of diverse 




Figure 3: Different Interleukins involved in Helper T cell differentiation. In this process mediated by antigen presenter 
cells the cytokine microenvironment determinates the T cell fate[22]. On the bottom, antigen presentation procedure 
between APCs and T cells, mediate by TCR and MHCI/MHCII. 
  
Citotoxic T Cells (CD8) 
Citotoxic T Cells can induce apoptosis in malignant tumoral cells, or those cells affected by 
intracellular pathogens; this defense against abnormal “self-cells” (so called cellular immunity) 
is mediated by the liberation of cytolytic granules. This vesicles contain pore-forming proteins, 
proteases, granulolysins (which degrade membrane lipids) and ligands for membrane death 
receptors (as CD95)[24].  
This granules are liberated after the recognition between target and T cells, the creation of pores 
unstabilize the cell, allowing proteases to reach the mitochondria and DNA. 
Citotoxic T Cells also have an important role in the defense against virus and tumor growth 
through the secretion of IFN- γ and TNF-α [24]. 
B cells (CD19) 
In contrast to citotoxic T cells, Bcells are in charge of humoral immunity, therefore the defense 
against the “outside” menace. B-cell antigen receptor is the surface immunoglobulin (or 
antibodys), an integral membrane protein with regions that allow them to recognize and bind 
limitless antigens (specific molecules or patterns) in a specific way. Thousands of identical copies 
of antibodies can be found on the surface of B cell, composed by a common domain and a 
variable domain, the variable region allow the antigen-binding process through non- covalent 
forces. Therefore the 3D structure of the light and heavy chains that conform this domain play 
a mandatory role[25].  
This antigen recognition triggers the activation of B-cells, due to the association of C-terminal 
portion of the antibodies with protein kinases[24].  This signaling process provokes a 
morphological change in B cells that multiply to become secretory factories of soluble 
antibodies.  
Activated proliferating B cells that present more affinity for the antigen are selected for 
further replication and multiplication, providing a stronger response in long-lasting 
infections, with refined antibody specificity.  When the menace is eliminated, depending on 
the antigen, the adjuvant and the infection route, distinct types of memory B cells can be 
gen-erated. Those clones of B cells with higher antibody specificity will be conserved as 
quiescent B cells, that will execute a quicker and stronger response in further exposures to 
the same antigen, as each infection will increase the amount of existing quiescent B 
cells[26].  
Natural Killer (CD56) 
NK cells constitute a third lymphoid line derived from a common, despite of that they do not 
present specific receptors for antigen recognition[27], either TCR or antibodies and not 
necessarily maturate on the thymus. NK cells have the highest cytotoxic capacity[28] and 
mediate the defense against intracellular pathogens and tumoral cells. Furthermore, activated 
NK cells are able to secrete matrix metalloproteinases (MMPs) for tissue remodeling, and also 
regulate of immune response. They are able to self-renew  and proliferate and after that they 
return to a quiescent state [29]. 
Lymphoid Progenitor Cells (CD34+) 
Also referred as Hematopoietic stem cells, lymphoid progenitor cells are pluripotent cells that 
can produce mature immune cells such as erythrocytes, leukocytes, platelets, and lymphocytes 
undergoing multiple divisions[30]. They are produced in the bone marrow, where they stay 
much of the time until they migrate into the blood or other tissues, differentiate into 
components of the blood or overcome apoptosis. They have an incredible grade of plasticity 
being able to transform even into epithelial cells.  
Methodologies to identify VEGs 
Different computational approaches and statistical models have been developed to identify 
VEGs from scRNA-Seq. Considering that in scRNA-seq count data, expression mean and 
variance are positively correlated different approaches have been taken in order to avoid VEGs 




scVEGs algorithm starts by assuming that scRNA-Seq follows a binomial distribution[7], where α 
represents biological dispersion and β represent the different sources of technical variation 
parameter, being therefore proportional to mean expression(μ) and constant through all the 
dataset.  Considering that, it obtains α and β parameters regressing log10(CV) on the 
log10(mean), using  robust local regression (locfit package),  finally it implements nonlinear 
least-squares after subsampling the fitted data points to avoid overfitting of the regression[7] 
(Figure 5).  
Finally, the variability of the genes is determined by the difference between the modelled 
variability for the observed mean, and the observed variability. Finally this differences are 
assumed to follow a normal distribution, fitted using kernel density estimate (Figure 5). Given 
that, those genes with a pvalue <0.05 according to the obtained distribution are selected as 
VEGs. 
 
Figure 5 Representation of  scVEGS procedure for expected variance calculation through regression adjustment on a 
log10CV vs log10mean plot and normal distribution adjustment (using kernel density) over the histogram of observed 
distances between VEGs (green dots) and expected variance (red regression line, nls)[7]. 
Seurat 
Seurat[31] encloses three different methods for VEGS assessment. In typical SC Data analysis 
workflow, VEGs are used as features to cluster different cell population by mean expression. 
Therefore performing a classic differential expression analysis on average expression but 
focusing in those genes that present more variability within the sample.  
VST (Seurat::VST): In a similar way to scVEGS, SEURAT::VST method Fit   local polynomial 
regression LOESS to adjust a log(variance) log(mean) plot. LOESS perform a smooth regression 
Figure 4: Mathematical representation of variability distribution in scRNA-Seq according to the binomial 
distribution of variability. In scVEGs methodology α represents biological dispersion and β represent the 
different sources of technical variation parameter 
curve adjusted to the observed data, establishing the curve values as the expected variance for 
those genes with a given mean value. Finally, a standardized variance is calculated, as the ratio 
between the observed variance of each gene  and the expected variance calculated by the 
model. This procedure was recently implemented in Seurat 3.0.2 release (June 2019).  
Mean.Var.Plot (Seurat::MVP): calculate average expression and dispersion for each feature. 
Next, divides features into 20 bins based on their mean.exp , calculates z-scores for dispersion 
within each bin to determinate VEGs. Identify variable features while controlling relationship 
between variability and mean. 
Dispersion (Seurat::DISP): This methodology calculates de Standard deviation of genes (SD) and 
select those n top features according to a given parameter (established on 2000 by default).  
OBJECTIVES 
In this project, we aim to characterize whether gene expression variability can characterize cells 
and tissues in both scRNA-Seq data (of clonal and more complex populations) and bulk RNA-Seq 
data of blood samples. Methods developed for the identification of VEGs from scRNA-Seq data 
will be applied to both Bulk and scRNA-Seq data.   
 
MATERIAL AND METHODS 
Datasets 
In order to address the biological question we have put together the following datasets of 
immune cells obtained from human blood samples (Table 2). As a whole they are particularly 
interesting, as they have the particularity of being different pure cell populations selected by 
flow cytometry (Fluorescence-activated cell sorting, FACS) using the same membrane  markers 
for the gating strategy in both Single cell RNA Seq and Bulk RNA Seq experiments. There is data 
from fully differenciated and pluripotent immune cells (as we have CD34 stem cells and fully 
developed lymphocytes (B & T Cells…NK ). Also from cells with different degrees of relationship 
(for example, T Helper and T Citotoxic cells are closely related) and even we have cells from   
myeloid (CD14), and lymphoid lineage (CD19,CD4,CD8,CD56). Finally, all of the samples retain 
similarity for being part of the PBMCS cell class, we have considered that identifying cell 
subtypes from very differentiated cell types by VEGs could be deceiving, as we would observe 
relevant differences just by randomly sampling part of the expressed genes.  
Finally, as the cherry on the top, we have an extra dataset for the whole PBMCs as a 
representation of a heterogeneous sample with the same expression profile.  
 
Table 2: Characteristics of the different datasets (from SC-RNA-Seq and Bulk RNA-Seq data) that were employed in the 
present manuscript. SC RNA-Seq data was obtained from 10x Genomic repository (Cell Rangel 1.0.1) 
https://support.10xgenomics.com/single-cell-gene-expression/datasets and Bulk RNA-Seq data from GEO accession 
number GSE107011.   
  
Bioinformatic procedures 
R session info:  
R version 3.4.4 (2018-03-15).  
Platform: x86_64-w64-mingw32/x64 (64-bit) 
Running under: Windows >= 8 x64 (build 9200) 
 
The code for implementation of all the analysis (except from IPA for copyright issues) can be 
found on the R Markdown provided as Supplemental Material. The enclosed zip file also 
provides the complete session info, original datasets and necessary results to perform all the 
procedures in a standalone way.  
Supplemental Material can be found in the following url: 
https://drive.google.com/open?id=1danah76vp_aAFcm0eWH0-JE3Pud8xD-O  
SC data processing 
SC Data was downloaded from 10x genomics public repository. 
https://support.10xgenomics.com/single-cell-gene-expression/datasets/ (Cell Ranger 1.0.1) 
and processed with Seurat 3.0.2 package (release Jun 2019). Datasets were filtered for those 
cells presenting over 2500 or under 200 counts and with a mithocondrial counts percentage 
above 5% according to Seurat authors standard; after data was normalized using normalization 
method “Log-Normalized” (a Seurat function that normalizes the expression values of each cell 
by the total expression, and multiplies this by a scale factor (10,000 by default), after that 
resulting values are log-transformed (natural logarithm)), and processed according with the R 
Markdown provided in Supplementary Files.   
Bulk Data processing 
Bulk RNA-Seq data from TPM Normalized data was downloaded from GEO accession number 
GSE107011 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE107011 (Supplementary 
File) and grouped according to authors nomenclature for each kind of cell [32]. 
Data was log normalized (performing the nature logarithm of 1+(expression matrix)) and genes 
expressed in less than 70% of the samples for each of the cell datasets were filtered out. 
Genes were annotated as hgnc gene symbols using ensemble database and biomaRt package as 
described in Supplementary Material 
Seurat VEG procedures 
For Dispersion procedure, the default parameter of n = 2000 was used.  
For Bulk processing the filtered and log normalized TPM expression data was loaded as a Seurat 
object avoiding any kind of preprocessing, raw.data slot was used as input for the VST 
FindVariables. 
scVEGS 
scVEGS was run using the recommended default parameters (pval=0.1, pFlag= 1). 
For Bulk processing, the scVEG original function was modified in order to avoid the TPM 
transformation.  
Gene Set Enrichment analysis 
Functional annotation was performed using Ingenuity Pathway Analysis (QIAGEN 
Bioinformatics) Summer 2019 Release. VEG lists were contrasted to the whole Ingenuity 
knowledge database without using any value as Z-score substitute.  
Statistical Analysis 
Study of enriched molecular types and cell locations was performed using  Exact Fisher test of 
each cell line VEGs list with the matching complete dataset (variably and non-variably expressed 
genes) without filtering from the lists those genes with unknown function/location (labeled as 
“others”). P-value post-hoc correction was performed using FDR procedure, in this case we did 






As reported in the literature, the outcome of VEG determination algorithms (including those 
tested in this manuscript) are heterogeneous and depend on the datasets characteristics [12] 
(Table 3). In our experiment, all the algorithms determined a higher amount of VEGS in the most 
heterogeneous dataset, the PBMCS, and shared a significant amount of genes between them 
(Figure 6) (Of course this was not observed in Seurat::DISP, which always returns a fixed amount 
of features determined by its “n” parameter).  
SCData SEURAT::VST scVEGS SEURAT::MVP Seurat::DISP 
CD14 470 54 520 2000 
CD19 106 91 472 2000 
CD34 264 431 400 2000 
CD4 160 158 288 2000 
CD56 99 191 413 2000 
CD8 88 211 356 2000 
PBMCS 1165 2090 995 2000 
Table 3: Obtained VEGs in SC-RNA-Seq datasets with each of the tested methodologies. Note that Seurat::DISP function 
requires an output parameter that determines the number of obtained features, 2000 by default.  
In all of the situations, SEURAT::MVP VEG are almost contained in the set obtained by the 
dispersion method, this would suggest that dispersion and SEURAT::MVP method are 
performing similarly, with the dispersion method being less strict in the selection of the most 
variable genes and therefore more prone to type I error. In addition, and because the dispersion 
method has no threshold for feature selection, it always returns 2000 features (as the default 
Seurat parameter). 
Figure 6: Venn Diagrams of VEGs lists obtained on SC-RNA-Seq with Seurat methodologies (SEURAT::VST (Blue), 
SEURAT::MVP (Green) and Seurat::DISP (Red)) on PBMCS (Right) and CD8 (left). Note that circle sizes are not 


















Regarding scVEGS and SEURAT::VST (being two methods that model the expected dispersion in 
order to determine which genes present a higher variability, and getting rid of the impact of 
average expression) and worked smoothly (Figure 7).  Both delivered gene lists that shared a 
high complementarity in PBMCS datasets, being more divergent in more homogenous samples 
(Figure 7).  
 
 
Figure 7: Venn Diagrams of VEGs lists obtained on SC-RNA-Seq with Seurat SEURAT::VST and scVEGs methodologies 
(scVEGS (Blue) and SEURAT::VST (Red)) on PBMCS.  
 
Bulk  
In order to be able to analyze Bulk-RNA-Seq data with ScVEGs package, a modified scVEG 
function was applied in order to avoid a double TPM normalization, allowing the input of Bulk 
RNA-Seq data matrix performed correctly. With this modification the method performed 
correctly but it didn't detect any VEGs in  those datasets, probably as a consequence of the 
highest average expression values obtained on the Bulk data methodology and the smaller 
Figure 8: Output results of applying scVEGs methodology in SC-RNA-Seq (right) and Bulk-RNA-Seq (left) PBMCs datasets. 




dispersion observed (measured as CV) (Figure 8).  This output did not changed regardless of the 
homogeneity or sample size of the analyzed dataset.   
Seurat methods:  
Out of the three variability measurement methods implemented in Seurat, SEURAT::VST was 
the only one that performed correctly when a bulk TPM log-normalized matrix was given as 
input. Using 1.5 threshold for the adjusted variance for feature selection as in the case of single 
cell data returned very large lists of variables genes. Given that, we decided to apply a more 
restrictive cutoff point of 3.0 (meaning that the genes would have to showcase 3 times more 
variance than the variance estimated for a gene with the same expression).  
When compared with the SC results for the same cell type it can be observed that even in the 
most heterogeneous samples (PBMCS) the obtained lists share a very low concordance with 
their SC counterparts (Figure 9).  This is especially relevant considering that the Bulk-derivated 
gene lists contain more than 1.000 features for every cell type (Table 4). In this datasets, the 
total number of samples per group (n=4 in CD34 and CD 56) is the main factor affecting the 
amount of obtained VEGs. 
 
Table 4 Obtained VEGs in SC-RNA-Seq and Bulk-RNA-Seq datasets using SEURAT::VST methods. 
Taking into consideration the observed divergence between the different methods (as 
previously reported[12], we decided to choose a methodology that could be used in both 
datasets in order to reduce the methodological bias. Particularly, if we expect to compare SC vs 
Bulk data is mandatory to choose a methodology that allow us to correct the value of dispersion 
in regards of the mean expression, due to the inherent differences between bulk RNA 
sequencing and Single Cells RNa Sequencing (with an increased amount of unexpressed genes 
and lower intensities) . Considering this, we decided to choose SEURAT::VST as the reference 
methodology.  
Figure 9: Venn Diagrams of VEGs lists obtained on Bulk (Blue) vs SC-RNA-Seq (Red) using Seurat VST methology 









 Comparing variability profiles 
We have contrasted the standardized variability obtained with Seurat::VST of paired datasets 
(SC vs Bulk) to compare the variability profile obtained with both techniques. 
Interestingly we have also found that despite of scRNA-seq, where expression mean and 
variance are positively correlated, in Bulk RNA Seq they are inversely correlated. 
Comparing only the common genes in Bulk and Single cell datasets for each cell type (Figure 10, 
11) we can have a more accurate comparison  of the actual variability distribution differences 
between techniques, considering that the total genes per cell in SC is more limited than in bulk 
sequencing(Table 2). We have also plotted the profiles using the same x and y scale in order to 
get a better picture of the profiles to be compared (outliers removed). Outliers in Bulk variability 
distribution are a constant feature that do not get represented in this kind of histograms.  (Figure 
10).  
In this plot we can observe that PBMCS variability present a wider distribution, more similar to 
a log normal plot, with values way more distributed along the x axis in a more continuous way 
while the SC plot (negative binomial) have a distribution more centered around the 1.  
 
Figure 10: Variability histograms of common genes between Bulk (top) and SC-RNA-Seq (bottom) complete dataset of  
PBMCS (not limited to VEGs). Standardized variability is calculated by VST method dividing observed variability 
between expected variability for a specific gene regarding their level expressions.   Please note that in x and y axis 
have been homogenized for comparison meanings. At the very top it can be observed the original PBMCs graphic, 
shrinked by the presence of outliers in high values and shorter y axis.  
 Figure 11: Variability histograms of common genes between Bulk (top) and SC-RNA-Seq (bottom) complete dataset of 
CD14 (Monocyte) cells (not limited to VEGs). Standardized variability is calculated by Seurat::VST method dividing 
observed variability between expected variability for a specific gene regarding their level expressions. Please note that 
in x and y axis have been homogenized for comparison meanings, omitting Bulk.RNA-Seq standardized variability 
outliers 
A common feature that can be observed in the  bulk variance study using SEURAT::VST 
methodology is the existence of many variability outliers, resulting in something close to a log 
normal distribution, with no-negative values and a long tail. The appearance of outliers would 
be accentuated by the discrete amount of samples within each cell type in bulk datasets 
(compared to SC). As it can be observed in the Table 5 the outliers are generated because of the 
low average variability observed in Bulk data (calculated with the average 30.000 genes of each 
sample), and the innacurate variability measures obtained in small datasets with a number of 
samples that ranges from 4 to 30 (Table 2) . 
 
 
Table 5: Variability outliers present in Bulk-RNA-Seq PBMC dataset processed by SEURAT::VST methodology 
  
In addition, Bulk variability presents a wider distribution in the low values, achieving smaller 
densities than the single cell counterpart.  
In the other hand the SC, data distribution of variability is defined as a negative binomial, as 
described in the literature[9] without remarkable outliers and a higher density of values around 
1.  
Comparing the absolute variability deviation from SC to Bulk for each the gene in paired datasets 
SC-Bulk (Figure 12, 13) we can observe that the difference is centered on a value close to 1 and 
distributed in a normal-like way in PBMC. In more homogenous datasets, the distribution of 
difference values embiggens, centered in values closer to 1. In this scenario, a difference of 1 in 
the adjusted variability would mean that the Bulk observed variability will double the expected 
one for it means in comparison with the SC screening for the same cell type). 
 
Figure 12: Histogram representing the distribution of the absolute difference between adjusted variance obtained in 
SC-RNA-Seq data vs Bulk-RNA-Seq data in the same cell type (PBMCs) for each of the genes expressed in both datasets. 
Standardized variability is calculated by SEURAT::VST method dividing observed variability between expected 
variability for a specific gene regarding their level expressions. 
 Figure 13: Histogram representing the distribution of the absolute difference between adjusted variance obtained in 
SC-RNA-Seq data vs Bulk-RNA-Seq data in the same cell type (CD14) for each of the genes expressed in both datasets. 
Standardized variability is calculated by SEURAT::VST method dividing observed variability between expected 
variability for a specific gene regarding their level expressions  
  
Biological characterization through Variability in SC 
Gene Set Enrichment Analysis 
Functional enrichment analysis were performed using the lists of VEGs for each cell dataset.  IPA 
(Ingeniuty Pathway Analysis) software was used and each dataset was contrasted to the whole 
IPA knowledge base database, in order to determine if the VEGS could characterize the biological 
activity of the cells. Moreover we were interested in determine whether the VEG profiles could 
allow us to characterize each of the different cell types. (Figure 14). In fact, we can observe that 
genes that present a high variability in their expressed profiles are related with biological 
processes involved or related with immune response.   
 
Figure 14: Dot plot representing the top 4 Enriched pathways in VEGs (identified by GSEA analysis of SEURAT::VST 
VEGs gene lists in SC-RNA-Seq data) for each cell type in SC-RNA-Seq data analyzed with SEURAT::VST method. Dot 
size is proportional to the number of VEGs identified for each pathway and heat colour represents BH correction p-
value (representing red the smaller pvalues).  Grey dots represent pathways that were identified on the cell lines VEGs 
but not in a significantly enriched after BH correction. 
Despite of having the longest list of VEGs (and considering that we performed a simple over-
representation analysis without associated Z scores). PBMCs show smaller log values than those 
more homogenous samples as CD34, CD4 and CD14.  
In contrast, no enriched pathways were found for CD19 after Bonferroni-Hochberg multiple 
testing correction is applied; this could be a direct consequence of having the smallest VEGs list 
among all the cell lines. This seems like a feature of the cell line itself, as the technical parameters 
of this dataset do not differ from the other in terms of total cells (10.000) or average reads per 
cell (25.000). CD56 (NKs) also present a slightly lower variability than the other lymphoid cells.  
CD8 (Citotoxic T cells) presents a profile of intermediate variation, similar to PBMCs. This can 
also be observed if we compare those pathways that are significant in more than 4 cell lines 
(Figure 15).  
 Figure 15: Dot plot representing pathways that were significantly enriched in VEGs lists in more than 4 of the 7 cell 
lines in SC-RNA-Seq data analyzed with SEURAT::VST method. Dot size is proportional to the number of VEGs identified 
for each pathway and heat colour represents BH correction p-value (representing red the smaller pvalues).  Grey dots 
represent pathways that were identified on the cell lines VEGs but not in a significantly enriched after BH correction. 
Observing those pathways that are significantly enriched exclusively in one of the different cell 
types, but only considering the top 30 pathways for each cell.  (Figure 16). We can observe how 
CD14 and PBMCs have a more divergent variability profile, for being either a cell type from a 
different lineage (or a heterogeneous cell sample (where variability arises). Due to the shared 
lymphoid lineage of all the other cells, (or the actual non-enrichment as in the case of CD19) 
there are no many enriched unique functions in only one cell type. 
 
Figure 16: Dot plot representing pathways that were significantly enriched in VEGs lists exclusively in 1 of the 7 cell 
lines and also between the top 30 results for each cell line in SC-RNA-Seq data analyzed with SEURAT::VST method. 
Dot size is proportional to the number of VEGs identified for each pathway and heat colour represents BH correction 
p-value (representing red the smaller pvalues).  Grey dots represent pathways that were identified on the cell lines 
VEGs but not in a significantly enriched after BH correction. 
If we take a closer to the top 4 enriched pathways we can find out very interesting results in 
terms of biological characterization (despite of the fact that a lot of features and pathways are 
shared through several cell types due to their similar lineage, making this analyze more 
challenging). For example, Granzyme signaling is enriched in NK and T cytotoxic cells, granzyme 
is a serines protease that are secreted by NK and CD8 cytotoxic granules as a mechanism of 
defense against tumoral and viral infected cells[33]. [34]  
Il17A signaling, a interleukin involved in T cell differentiation and regulatory mechanisms (Figure 
3) is exclusively enriched in CD4 and CD8 (T cells). Also, antigen presentation pathways are 
enriched in T helper, T cytotoxic and monocytes, being those cell types involved in the antigen 
presentation procedure (Figure 3). 
Monocytes presents several enriched  pathways involved in Rho GTP-ase pathways, this 
molecules are involved in monocyte motility response through tissues [35]. Being monocytes 
the most distinctive of those homogeneous and differentiated cell types, they are also easier to 
characterize, having several Rho-related pathways exclusively enriched in this cell type (as there 
are no other myeloid cells in our dataset) (Figure16). Similarly, monocytes and NK cells presents 
enriched pathways in remodeling epithelial adherens junctions, as they must infiltrate tissues as 
part of their biological functions [15]. 
Biological features enrichment 
We performed a secondary analysis of biological significance across the immune cell types. We 
annotated the obtained VEGs in terms of both molecule type and cell location using Ingeniuty 
pathways database in order to determine if those biological features were enriched in VEGs in 
contrast to the whole whole geneset in any of the cell types. 
Results can be consulted in Table 6. As expected, CD 34, progenitor stem cells, showcase the 
higher enrichment in terms of variable genes in both cell location and biological functions, being 
undifferentiated cells with high plasticity.  
 CD14 (Monocytes), the only cell of myeloid lineage in the datasets have a representative pattern 
of variability in both cell location and molecular type, whereas cells from lymphoid lineage (CD 
8, CD4 and CD56) also shares a distinctive and common pattern that differs  from that on the 
myeloid cells.. In terms of molecule function, Cytokynes are enriched in lymphoid cells, 
something biologically representative of this immune lineage that secrete cytokines to mediate 
their activity and regulation on other immune cells, in the other hand kynases are over-
represented in the only myeloid related cell, the CD14.  
Regarding CD 34 (Table 6) they present enrichment in most of the locations, as it was observed 
in the molecular type data. Regarding the lymphoid lineage, they share the over-representation 
of extracellular components. 
In both cases, CD8 and CD4 (cytotoxic T lymphocytes and T helper lymphocyte), those most 
tightly related cells share a yet another common pattern of enriched features in their VEGs), 
regarding both functions and locations with a higher representation of cytokines, 
transmembrane receptors and extracellular components. This characteristic is also observed in 
the PBMCS. In the case of PBMCs, being a heterogeneous cell type, part of their VEGs are a 
reflection of that inner heterogeneity, but as they are composed of mostly T cells (60% of total 
PBMCS (Table 1). Their functional enrichment within those VEGs summarize the most relevant 
features of T Cells. Finally, B cells (CD19) show no enrichment on either types of molecule or cell 
location, as observed in the pathway enrichment analysis, this could be a consequence of the 
quiescent status of B in the absence of external antigens or just a characteristic of the obtained 
sample. Further analysis indifferent conditions should be done in order to address this. 
Biological characterization through Variability in Bulk 
In bulk data the enriched pathway analysis returned a larger amount different pathways, as the 
VEGs list were more extense (Table 4), most of those pathways are related with the immune 
system. But in contrast with the single cell data, they show almost no difference between cell 
Table 6: Results of biological features enrichment analysis of VEGs for celular location (right) and molecular 
function (left) after FDR correction. VEGs were obtained through VST methodology in SC-RNA-Seq Data. 
types, showcasing similar patterns and pvalues. Despite of that, some interesting results can be 
cherry-picked in the top5 most enriched pathways for each cell type (Figure 17) but doesn’t 
seem like we are being able to characterize cell types and we are just observing immune cells 
expression patterns.  
 
Figure 17: Dot plot representing the top 5 Enriched pathways in VEGs (identified by GSEA analysis of SEURAT::VST 
VEGs gene lists in SC-RNA-Seq data) for each cell type in Bulk-RNA-Seq data analyzed with SEURAT::VST method. 
Please note that in this case top 5 was considered due to the homogeneity of the results. 
Finally, the analysis of the top 30 pathways that are enriched in a single cell type and not in the 
rest of the cells (in order to observe unique patterns of variability) returned one single pathway 
in one cell type without any biological relevance. Increasing that value to 100 (because the 
higher amount of VEGS reported a large amount of enriched pathways) allowed us to obtain 
some results, but yet again, they are not very promising. (Figure 18). 
 Figure 18: Dot plot representing pathways that were significantly enriched in VEGs lists exclusively in 1 of the 7 cell 
lines and also between the top 100 results for each cell line in Bulk-RNA-Seq data analyzed with SEURAT::VST method. 
Please note that in this case the number of results has to be set from 30 to 100 in order to obtain results due to the 
homogeneity of the results.  
Regarding the functional enrichment analysis, similar outcome was obtained, with almost every 
function and locations enriched for all of the different cell lines, without any kind of difference 
regardless of function, differentiation status or relationships. Only a similar over-representation 
of locations was found on T Cells (CD4 and CD8). In the case of molecular function comparison, 





Table 7: Result of biological features enrichment analysis of VEGs for 
celular location after FDR correction. VEGs were obtained through 
SEURAT::VST methodology in Bulk-RNA-Seq Data. Note that molecular 
function results are not being displayed because of the length of the table 






Considering all the results presented in the current manuscript we can confirm that variability 
profiling allow us to characterize the biology of the sample in single cell data. 
Methodologies 
As previously reported[12] methodologies for VEG determination in SC sequencing have 
discrepancies in their result, and methods that minimize the effect of the direct correlation 
between mean and dispersion are necessary to avoid picking only those highly expressed genes. 
SEURAT::VST have proved to provide meaningful results when processing single cell datasets, 
and being to process Bulk RNA-Seq datasets.   
Variability comparison 
Regarding the variability profile of bulk and single cell data, instead of the double binomial 
distribution presented by SC dispersion data as reported in the literature[1] the bulk dispersion 
data presents a log normal distribution.  Studying the difference between the adjusted variability 
we can address that there is a technical bias in associated to Bulk RNA-Seq data. This effect gets 
more accentuated in homogeneous cell cultures. 
SEURAT::VST SC 
The gene set enrichment analysis demonstrated that identified VEG genes are involved in 
different immune related processes across the different cell types. Those pathways present cell 
type specificity, with enriched features that reflect the biological function of the different cell 
types. The high similarity between datasets proves that VEGs profiling analysis are cell type 
specific in the case of single cell RNA-Seq. 
VEG analysis suggest that those as genes prone to be adapted through external stimulus (for 
example as an micro-environmental response or a differentiation procedure)[2].  
All of the studied features (pathways, gene expression location and molecular type) presented 
results that were coherent in terms of identifying related cell types (CD4 & CD8 similarities), 
different lineages (lymphoid vs myeloid patterns), stages of differentiation and heterogeneity 
(PBMCS) vs homogeneity of datasets. In the case of CD39, progenitor cells, they presented a 
more diverse variability pattern in terms of functions and locations, this would reflect not only 
the different stages of differentiation in which this cells can be found, but also the high 
adaptability and plasticity of this precursor cells. 
Regarding PBMC dataset, because of the heterogeneity of the sample[15], the total amount of 
VEGs will be always superior than in homogeneous samples.  In addition, considering the 
percentage of each immune cell type in PBMCs (Table 1), the functional enrichment of this 
cellular type is highly influenced by the lymphoid T cells (CD4 & CD8).  
With all the provided data, we can conclude that variability measured by SEURAT::VST 
procedure allow us to characterize the biology of immune cells, delivering meaningful results 
that are not just associated with technical issues but biological procedures.  
SEURAT::VST Bulk  
When analyzing Bulk RNA-Seq data, the lack of difference between cell lines, heterogeneous and 
homogeneous datasets or related and unrelated cell lines, and the low concordance between 
Bulk and SC results points out that SEURAT::VST is not providing an accurate determination of 
VEGS in bulk data. 
Despite of the good results obtained in SC to characterize the different cell types. The results 
obtained, unveils something that preliminary data analysis already pointed out, the 
SEURAT::VST procedure is performing a weak and  selection on VEGS , with an unusual Type I 
error, in a similar way as the dispersion method would perform in single cell datasets. Therefore, 
ranking those genes that present high variability and being unable to control the effect of the 
mean expression. In the future, we will need to obtain specific methodologies that allow us to 
obtain the most variable genes in Bulk datasets while being able to correct the effects of the 
mean. There have been some simplistic approaches to the date[36] that function similarly to 
SEURAT::MVP procedure, creating bins of each average expression and finding the top variable 
genes within each bin, but more accurate methods must be developed, if we expect to obtain 
meaningful results.  
Finally, the low amount of samples that are obtained in Bulk RNA seq experiments are still the 
major constraint in the labor of assessing VEGS, a statistical approach that requires a larger 
sample size than mean gene expression studies.  
Future approaches 
Considering the results presented in this manuscript were limited by the time available for the 
present realization (300h) and the diverse methodologies that were implemented in different 
datasets, there are many challenges that should be tackled in the future in order to keep on the 
present research line. 
Develop a decision tree algorithm (supervised classifier) with the top 5 VEGs features for each 
cell type to classify scRNA-Seq dat.  We started this procedure for the current manuscript, but 
having only 1 variation measurement for each cell type (despite of having 3.000 cells we get a 
single standardized variance result for each cell line). In order to approach this problem we 
would perform bootstrap variability calculation with random subsets of the original dataset in 
order to get over at least 100 variability measurements per cell line, and then perform the 
classifying algorithm.  
Validate the reported SC results with SEURAT::VST methodology in an external dataset. In case 
of not being possible to find a similar dataset, perform a new study using a test/validation 
approach within the existing SC RNA-Seq datasets.   
Use overlapping features between different methods (SEURAT::VST/scVEGS/SEURAT::MVP) as 
VEGs lists and compare the obtained results with the already reported results.  
Obtaining a bigger dataset of Bulk-RNA-Seq (PBMCs and cell lines), to address the factor of 
sample size in a more objective way.  
Finding a specific Bulk methodology to determine VEGs: 
Able to perform within the same condition (and not as a differential comparison 
between two conditions as MDSeq). 
Not relying on modelling expected variability, to avoid the issues that arised as a 
consequence of low variability in Bulk RNA-Seq data. 
Avoiding simplistic approaches that would lead to poor results for ignoring the mean 
bias in variability.  
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